The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key markets has introduced significant uncertainty . Investors are now grappling with the impact of rival m